Literature DB >> 21263959

Current treatment of psoriasis.

J D Epstein.   

Abstract

Psoriasis is a relatively common chronic dermatosis that is genetically determined and environmentally influenced. Because it is ideopathic, therapy is presently supportive, directed at optimal control, patient understanding, and prevention of recurrence. Because this multifactorial condition may involve skin and nails, musculoskeletal system, and psyche in various combinations and degrees, an organized co-operative team approach involving the patient, the family, and appropriately experienced health-care providers is most beneficial. Many topical and systemic medications, as well as physical therapeutic modalities, both established and innovative, are available for use sequentially or in various combinations to suite the individual and his/her particular psoriasis. This brief review will outline the better established dermatologic therapeutic principles and options currently available for this patient group.

Entities:  

Year:  1987        PMID: 21263959      PMCID: PMC2218552     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  27 in total

1.  ROLE OF TRAUMA IN ISOMORPHIC RESPONSE IN PSORIASIS.

Authors:  E M FARBER; R J ROTH; E ASCHHEIM; D D EDDY; W W EPINETTE
Journal:  Arch Dermatol       Date:  1965-03

2.  The approach to psoriasis.

Authors:  J T INGRAM
Journal:  Br Med J       Date:  1953-09-12

Review 3.  Steroid addiction.

Authors:  A M Kligman; P J Frosch
Journal:  Int J Dermatol       Date:  1979 Jan-Feb       Impact factor: 2.736

4.  Clearance of psoriasis with low dose cyclosporin.

Authors:  C E Griffiths; A V Powles; J N Leonard; L Fry; B S Baker; H Valdimarsson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

Review 5.  An appraisal of current systemic chemotherapy for psoriasis.

Authors:  E M Farber; D Pearlman; E A Abel
Journal:  Arch Dermatol       Date:  1976-11-29

Review 6.  Position paper--PUVA therapy. American Academy of Dermatology.

Authors:  D R Bickers
Journal:  J Am Acad Dermatol       Date:  1983-02       Impact factor: 11.527

7.  Psoriasis and stress.

Authors:  R H Seville
Journal:  Br J Dermatol       Date:  1977-09       Impact factor: 9.302

Review 8.  Topical clobetasol-17-propionate: review of its clinical efficacy and safety.

Authors:  E A Olsen; R C Cornell
Journal:  J Am Acad Dermatol       Date:  1986-08       Impact factor: 11.527

9.  The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis.

Authors:  B S Baker; C E Griffiths; S Lambert; A V Powles; J N Leonard; H Valdimarsson; L Fry
Journal:  Br J Dermatol       Date:  1987-04       Impact factor: 9.302

Review 10.  Drugs in exacerbation of psoriasis.

Authors:  E A Abel; L M DiCicco; E K Orenberg; J E Fraki; E M Farber
Journal:  J Am Acad Dermatol       Date:  1986-11       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.